Piperidine, pyridine alkaloid inhibition of fetal movement in a day 40 pregnant goat model

Food and Chemical Toxicology

Volumn 58, Issue , 2013, Pages 8-13

  Green, Benedict T ^a   Lee, Stephen T ^a   Welch, Kevin D ^a   Pfister, James A ^a   Panter, Kip E ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Fetal movement; Piperidine alkaloids; Pyridine alkaloids

Indexed keywords

ALKALOID; ALPHA CONOTOXIN EI; ALPHA CONOTOXIN GI; ANABASINE; CONOTOXIN; LOBELINE; MYOSMINE; NICOTINIC RECEPTOR; PIPERIDINE DERIVATIVE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE POTENTIAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; FETUS; FETUS MOVEMENT; GOAT; HUMAN; HUMAN CELL; NONHUMAN;

ALPHA CONOTOXIN; CTX; FETAL MOVEMENT; NACHR; NICOTINIC ACETYLCHOLINE RECEPTOR; PIPERIDINE ALKALOIDS; PYRIDINE ALKALOIDS;

ALKALOIDS; ANABASINE; ANIMALS; CELL LINE, TUMOR; CONOTOXINS; FEMALE; FETAL MOVEMENT; GOATS; HUMANS; LOBELINE; MODELS, ANIMAL; NICOTINIC AGONISTS; PREGNANCY; RECEPTORS, NICOTINIC;

EID: 84877348282     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.04.009     Document Type: Article

References (55)

1. Arias H.R., Blanton M.P. Alpha-conotoxins. Int. J. Biochem. Cell Biol. 2000, 32:1017-1028.
2. Azam L., McIntosh J.M. Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors. Acta Pharmacol. Sin. 2009, 30:771-783.
3. Billen B., et al. Molecular actions of smoking cessation drugs at α4β2 nicotinic receptors defined in crystal structures of a homologous binding protein. Proc. Natl. Acad. Sci. USA 2012, 109:9173-9178.
4. Bowman W.C., Sanghvi I.S. Pharmacological actions of hemlock (Conium maculatum) alkaloids. J. Pharm. Pharmacol. 1963, 15:1-25.
5. Briggs C.A., McKenna D.G. Activation and inhibition of the human alpha7 nicotinic acetylcholine receptor by agonists. Neuropharmacology 1998, 37:1095-1102.
6. Brioni J.D., et al. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur. J. Pharmacol. 1993, 238:1-8.
7. Clemens K.J., et al. The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. Int. J. Neuropsychopharmacol. 2009, 12:1355-1366.
8. Damaj M.I., et al. Pharmacology of lobeline, a nicotinic receptor ligand. J. Pharmacol. Exp. Ther. 1997, 282:410-419.
9. Damle V.N., Karlin A. Effects of agonists and antagonists on the reactivity of the binding site disulfide in acetylcholine receptor from Torpedo californica. Biochemistry 1980, 19:3924-3932.
10. Decker M.W., Majchrzak M.J., Arnerić S.P. Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol. Biochem. Behav. 1993, 45:571-576.
11. Dwoskin L.P., Crooks P.A. Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery. J. Pharmacol. Exp. Ther. 2001, 298:395-402.
12. Dwoskin L.P., Crooks P.A. A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse. Biochem. Pharmacol. 2002, 63:89-98.
13. Felpin F.X., Lebreton J. History, chemistry and biology of alkaloids from Lobelia inflata. Tetrahedron 2004, 60:10127-10153.
14. Forsyth C.S., et al. Effect of coniine on the developing chick embryo. Teratology 1994, 49:306-310.
15. Forsyth C.S., et al. Comparison of nicotinic receptor binding and biotransformation of coniine in the rat and chick. Toxicol. Lett. 1996, 89:175-183.
16. Forsyth C.S., Frank A.A. Evaluation of developmental toxicity of coniine to rats and rabbits. Teratology 1993, 48:59-64.
17. Furer V., et al. Nicotiana glauca (tree tobacco) intoxication-two cases in one family. J. Med. Toxicol. 2011, 7:47-51.
18. Giniatullin R., Nistri A., Yakel J.L. Desensitization of nicotinic ACh receptors: shaping cholinergic signaling. Trends Neurosci. 2005, 28:371-378.
19. Gray W.R., et al. Peptide toxins from Conus geographus venom. J. Biol. Chem. 1981, 256:4734-4740.
20. Green B.T., et al. Fetal-muscle type nicotinic acetylcholine receptor activation in TE-671 cells, and inhibition of fetal movement in a day 40 pregnant goat model by optical isomers of the piperidine alkaloid coniine. J. Pharmacol. Exp. Ther. 2013, 344:295-307.
21. Green B.T., et al. Actions of piperidine alkaloid teratogens at fetal nicotinic acetylcholine receptors. Neurotoxicol. Teratol. 2010, 32:383-390.
22. Green B.T., et al. Piperidine alkaloids: human and food animal teratogens. Food Chem. Toxicol. 2012, 50:2049-2055.
23. Groebe D.R., et al. Alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors. Mol. Pharmacol. 1995, 48:105-111.
24. Hackshaw A., Rodeck C., Boniface S. Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum. Reprod. Update. 2011, 17:589-604.
25. Hall J.G. Analysis of Pena Shokeir phenotype. Am. J. Med. Genet. 1986, 25:99-117.
26. Keeler R.F., Crowe M.W., Lambert E.A. Teratogenicity in swine of the tobacco alkaloid anabasine isolated from Nicotiana glauca. Teratology 1984, 30:61-69.
27. Kem, et al. Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors. J. Pharmacol. Exp. Ther. 1997, 283:979-992.
28. Kenakin T.P. A Pharmacology Primer: Theory, Applications, and Methods. third ed 2009, Elsevier, Academic Press, (Chapter 6).
29. Kleinsasser N.H., et al. Genotoxic effects of myosmine in human lymphocytes and upper aerodigestive tract epithelial cells. Toxicology 2003, 192:171-177.
30. Lee S.T., et al. Relative toxicities and neuromuscular nicotinic receptor agonistic potencies of anabasine enantiomers and anabaseine. Neurotoxicol. Teratol. 2006, 28:220-228.
31. Levin E.D., Christopher C.N. Lobeline-induced learning improvement of rats in the radial-arm maze. Pharmacol. Biochem. Behav. 2003, 76:133-139.
32. López-Vera E., et al. Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors. FEBS J. 2007, 274:3972-3985.
33. Luanratana O., Griffin W.J. Alkaloids of Duboisia hopwoodii. Phytochemistry 1982, 21:449-451.
34. Martinez J.S., et al. Alpha-Conotoxin EI, a new nicotinic acetylcholine receptor antagonist with novel selectivity. Biochemistry 1995, 34:14519-14526.
35. Moessinger A.C. Fetal akinesia deformation sequence. an animal model. Pediatrics 1983, 72:857-863.
36. Ochoa E.L., Chattopadhyay A., McNamee M.G. Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators. Cell. Mol. Neurobiol. 1989, 9:141-178.
37. Paladini D., et al. Pena-Shokeir phenotype with variable onset in three consecutive pregnancies. Ultrasound Obstet. Gynecol. 2001, 17:163-165.
38. Panter K.E., et al. Multiple congenital contractures (MCC) and cleft palate induced in goats by ingestion of piperidine alkaloid-containing plants: reduction in fetal movement as the probable cause. J. Toxicol. Clin. Toxicol. 1990, 28:69-83.
39. Panter K.E., et al. Comparison of cleft palate induction by Nicotiana glauca in goats and sheep. Teratology 2000, 61:203-210.
40. Panter K.E., et al. Congenital skeletal malformations and cleft palate induced in goats by ingestion of Lupinus, Conium and Nicotiana species. Toxicon 1990, 28:1377-1385.
41. Panter K.E., James L.F., Gardner D.R. Lupines, poison-hemlock and Nicotiana spp.: toxicity and teratogenicity in livestock. J. Nat. Toxins 1999, 8:117-134.
42. Panter K.E., Keeler R.F. Induction of cleft palate in goats by Nicotiana glauca during a narrow gestational period and the relation to reduction in fetal movement. J. Nat. Toxins 1992, 1:25-32.
43. Pena S.D.J., Shokeir M.H.K. Syndrome of camptodactyly, multiple ankyloses, facial anomalies and pulmonary hypoplasia. A lethal condition. J. Pediatr. 1974, 85:373-375.
44. Polizzi A., Huson S.M., Vincent A. Teratogen update: maternal myasthenia gravis as a cause of congenital arthrogryposis. Teratology 2000, 62:332-341.
45. Prince R.J., Sine S.M. Acetylcholine and epibatidine binding to muscle acetylcholine receptors distinguish between concerted and uncoupled models. J. Biol. Chem. 1999, 274:19623-19629.
46. Quin L.D. Alkaloids of tobacco smoke. I. Fractionation of some tobacco alkaloids and of the alkaloid extract of burley cigarette smoke by gas chromatography. J. Org. Chem. 1958, 24:911-914.
47. Quin L.D. Alkaloids of tobacco smoke. II. Identification of some of the alkaloids in burley cigarette smoke. J. Org. Chem. 1958, 24:914-916.
48. Roni M.A., Rahman S. Neuronal nicotinic receptor antagonist reduces anxiety-like behavior in mice. Neurosci. Lett. 2011, 504:237-241.
49. Shaw G.M., et al. Mid-pregnancy cotinine and risks of orofacial clefts and neural tube defects. J. Pediatr. 2009, 154:17-19.
50. Vogt S., Fuchs K., Richter E. Genotoxic effects of myosmine in a human esophageal adenocarcinoma cell line. Toxicology 2006, 222:71-79.
51. Wang H., Sun X. Desensitized nicotinic receptors in brain. Brain Res. Brain Res. Rev. 2005, 48:420-437.
52. Welch, et al. The role of the α7 subunit of the nicotinic acetylcholine receptor in the acute toxicosis of methyllycaconitine in mice. J. Appl. Toxicol. 2013, (Article first published online: 8 January 2013). 10.1002/jat.2851.
53. Wilson G.G., Karlin A. Acetylcholine receptor channel structure in the resting, open, and desensitized states probed with the substituted-cysteine-accessibility method. Proc. Natl. Acad. Sci. USA 2001, 98:1241-1248.
54. Zwickenpflug W., Meger M., Richter E. Occurrence of the tobacco alkaloid myosmine in nuts and nut products of Arachus hypogaea and Corylus avellana. J. Agric. Food Chem. 1998, 46:2703-2706.
55. Zwickenpflug W., Tyroller S. Reaction of the tobacco alkaloid myosmine with hydrogen peroxide. Chem. Res. Toxicol. 2006, 19:150-155.